Diebold (DBD) PT Lowered to $5 at JPMorgan
Tweet
Share
E-mail
Get Alerts DBD Hot Sheet
Price: $32.32 -1.85%
Rating Summary:
4 Buy, 8 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
4 Buy, 8 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
JPMorgan analyst Paul Coster lowered the price target on Diebold (NYSE: DBD) to $5.00 (from $6.50) while maintaining a Underweight rating.
Coster adjusts his model to reflect additional AG shares redemptions and expects shares to be put back in relatively short order. The analyst lowers his PT on higher interest costs.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Comcast Corp (CMCSA) PT Lowered to $48 at Pivotal Research
- Acrivon Therapeutics Inc (ACRV) PT Lowered to $22 at Jones Trading
- MarineMax (HZO) PT Lowered to $35 at Stifel
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
